Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide
• Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
McDermott, C. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening - Janssen, Matthew ELSEVIER, 2022, official journal of the European Society of Toxicology in Vitro, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:27 ; year:2013 ; number:6 ; pages:1693-1698 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.tiv.2013.04.015 |
|---|
| Katalog-ID: |
ELV022017968 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV022017968 | ||
| 003 | DE-627 | ||
| 005 | 20230623162810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tiv.2013.04.015 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013013000029.pica |
| 035 | |a (DE-627)ELV022017968 | ||
| 035 | |a (ELSEVIER)S0887-2333(13)00122-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.92 |2 bkl | ||
| 100 | 1 | |a McDermott, C. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| 264 | 1 | |c 2013 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. | ||
| 650 | 7 | |a PGE2 |2 Elsevier | |
| 650 | 7 | |a Pyocyanin |2 Elsevier | |
| 650 | 7 | |a Lipopolysaccharide |2 Elsevier | |
| 650 | 7 | |a Acetylcholine |2 Elsevier | |
| 650 | 7 | |a Inflammation |2 Elsevier | |
| 650 | 7 | |a Urothelium |2 Elsevier | |
| 700 | 1 | |a Chess-Williams, R. |4 oth | |
| 700 | 1 | |a Mills, K.A. |4 oth | |
| 700 | 1 | |a Kang, S.H. |4 oth | |
| 700 | 1 | |a Farr, S.E. |4 oth | |
| 700 | 1 | |a Grant, G.D. |4 oth | |
| 700 | 1 | |a Perkins, A.V. |4 oth | |
| 700 | 1 | |a Davey, A.K. |4 oth | |
| 700 | 1 | |a Anoopkumar-Dukie, S. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Janssen, Matthew ELSEVIER |t Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening |d 2022 |d official journal of the European Society of Toxicology in Vitro |g Amsterdam [u.a.] |w (DE-627)ELV009047719 |
| 773 | 1 | 8 | |g volume:27 |g year:2013 |g number:6 |g pages:1693-1698 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.tiv.2013.04.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.92 |j Gynäkologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 27 |j 2013 |e 6 |h 1693-1698 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
c m cm |
|---|---|
| matchkey_str |
mcdermottcchesswilliamsrmillskakangshfar:2013----:leainiaeycoieg2ni6eesfouohlaclsolwntetetih |
| hierarchy_sort_str |
2013 |
| bklnumber |
44.92 |
| publishDate |
2013 |
| allfields |
10.1016/j.tiv.2013.04.015 doi GBVA2013013000029.pica (DE-627)ELV022017968 (ELSEVIER)S0887-2333(13)00122-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.92 bkl McDermott, C. verfasserin aut Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Elsevier Chess-Williams, R. oth Mills, K.A. oth Kang, S.H. oth Farr, S.E. oth Grant, G.D. oth Perkins, A.V. oth Davey, A.K. oth Anoopkumar-Dukie, S. oth Enthalten in Elsevier Science Janssen, Matthew ELSEVIER Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening 2022 official journal of the European Society of Toxicology in Vitro Amsterdam [u.a.] (DE-627)ELV009047719 volume:27 year:2013 number:6 pages:1693-1698 extent:6 https://doi.org/10.1016/j.tiv.2013.04.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.92 Gynäkologie VZ AR 27 2013 6 1693-1698 6 045F 610 |
| spelling |
10.1016/j.tiv.2013.04.015 doi GBVA2013013000029.pica (DE-627)ELV022017968 (ELSEVIER)S0887-2333(13)00122-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.92 bkl McDermott, C. verfasserin aut Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Elsevier Chess-Williams, R. oth Mills, K.A. oth Kang, S.H. oth Farr, S.E. oth Grant, G.D. oth Perkins, A.V. oth Davey, A.K. oth Anoopkumar-Dukie, S. oth Enthalten in Elsevier Science Janssen, Matthew ELSEVIER Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening 2022 official journal of the European Society of Toxicology in Vitro Amsterdam [u.a.] (DE-627)ELV009047719 volume:27 year:2013 number:6 pages:1693-1698 extent:6 https://doi.org/10.1016/j.tiv.2013.04.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.92 Gynäkologie VZ AR 27 2013 6 1693-1698 6 045F 610 |
| allfields_unstemmed |
10.1016/j.tiv.2013.04.015 doi GBVA2013013000029.pica (DE-627)ELV022017968 (ELSEVIER)S0887-2333(13)00122-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.92 bkl McDermott, C. verfasserin aut Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Elsevier Chess-Williams, R. oth Mills, K.A. oth Kang, S.H. oth Farr, S.E. oth Grant, G.D. oth Perkins, A.V. oth Davey, A.K. oth Anoopkumar-Dukie, S. oth Enthalten in Elsevier Science Janssen, Matthew ELSEVIER Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening 2022 official journal of the European Society of Toxicology in Vitro Amsterdam [u.a.] (DE-627)ELV009047719 volume:27 year:2013 number:6 pages:1693-1698 extent:6 https://doi.org/10.1016/j.tiv.2013.04.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.92 Gynäkologie VZ AR 27 2013 6 1693-1698 6 045F 610 |
| allfieldsGer |
10.1016/j.tiv.2013.04.015 doi GBVA2013013000029.pica (DE-627)ELV022017968 (ELSEVIER)S0887-2333(13)00122-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.92 bkl McDermott, C. verfasserin aut Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Elsevier Chess-Williams, R. oth Mills, K.A. oth Kang, S.H. oth Farr, S.E. oth Grant, G.D. oth Perkins, A.V. oth Davey, A.K. oth Anoopkumar-Dukie, S. oth Enthalten in Elsevier Science Janssen, Matthew ELSEVIER Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening 2022 official journal of the European Society of Toxicology in Vitro Amsterdam [u.a.] (DE-627)ELV009047719 volume:27 year:2013 number:6 pages:1693-1698 extent:6 https://doi.org/10.1016/j.tiv.2013.04.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.92 Gynäkologie VZ AR 27 2013 6 1693-1698 6 045F 610 |
| allfieldsSound |
10.1016/j.tiv.2013.04.015 doi GBVA2013013000029.pica (DE-627)ELV022017968 (ELSEVIER)S0887-2333(13)00122-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.92 bkl McDermott, C. verfasserin aut Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide 2013 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Elsevier Chess-Williams, R. oth Mills, K.A. oth Kang, S.H. oth Farr, S.E. oth Grant, G.D. oth Perkins, A.V. oth Davey, A.K. oth Anoopkumar-Dukie, S. oth Enthalten in Elsevier Science Janssen, Matthew ELSEVIER Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening 2022 official journal of the European Society of Toxicology in Vitro Amsterdam [u.a.] (DE-627)ELV009047719 volume:27 year:2013 number:6 pages:1693-1698 extent:6 https://doi.org/10.1016/j.tiv.2013.04.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.92 Gynäkologie VZ AR 27 2013 6 1693-1698 6 045F 610 |
| language |
English |
| source |
Enthalten in Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening Amsterdam [u.a.] volume:27 year:2013 number:6 pages:1693-1698 extent:6 |
| sourceStr |
Enthalten in Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening Amsterdam [u.a.] volume:27 year:2013 number:6 pages:1693-1698 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Gynäkologie |
| institution |
findex.gbv.de |
| topic_facet |
PGE2 Pyocyanin Lipopolysaccharide Acetylcholine Inflammation Urothelium |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening |
| authorswithroles_txt_mv |
McDermott, C. @@aut@@ Chess-Williams, R. @@oth@@ Mills, K.A. @@oth@@ Kang, S.H. @@oth@@ Farr, S.E. @@oth@@ Grant, G.D. @@oth@@ Perkins, A.V. @@oth@@ Davey, A.K. @@oth@@ Anoopkumar-Dukie, S. @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV009047719 |
| dewey-sort |
3610 |
| id |
ELV022017968 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022017968</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623162810.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.tiv.2013.04.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013013000029.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022017968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0887-2333(13)00122-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.92</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McDermott, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PGE2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pyocyanin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipopolysaccharide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acetylcholine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelium</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chess-Williams, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mills, K.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, S.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farr, S.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, G.D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perkins, A.V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davey, A.K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anoopkumar-Dukie, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Janssen, Matthew ELSEVIER</subfield><subfield code="t">Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the European Society of Toxicology in Vitro</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV009047719</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1693-1698</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.tiv.2013.04.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.92</subfield><subfield code="j">Gynäkologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2013</subfield><subfield code="e">6</subfield><subfield code="h">1693-1698</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
McDermott, C. |
| spellingShingle |
McDermott, C. ddc 610 bkl 44.92 Elsevier PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| authorStr |
McDermott, C. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009047719 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.92 bkl Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium Elsevier |
| topic |
ddc 610 bkl 44.92 Elsevier PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium |
| topic_unstemmed |
ddc 610 bkl 44.92 Elsevier PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium |
| topic_browse |
ddc 610 bkl 44.92 Elsevier PGE2 Elsevier Pyocyanin Elsevier Lipopolysaccharide Elsevier Acetylcholine Elsevier Inflammation Elsevier Urothelium |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
r c w rcw k m km s k sk s f sf g g gg a p ap a d ad s a d sad |
| hierarchy_parent_title |
Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening |
| hierarchy_parent_id |
ELV009047719 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009047719 |
| title |
Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| ctrlnum |
(DE-627)ELV022017968 (ELSEVIER)S0887-2333(13)00122-7 |
| title_full |
Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| author_sort |
McDermott, C. |
| journal |
Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening |
| journalStr |
Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
1693 |
| author_browse |
McDermott, C. |
| container_volume |
27 |
| physical |
6 |
| class |
610 610 DE-600 610 VZ 44.92 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
McDermott, C. |
| doi_str_mv |
10.1016/j.tiv.2013.04.015 |
| dewey-full |
610 |
| title_sort |
alterations in acetylcholine, pge2 and il6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| title_auth |
Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| abstract |
• Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. |
| abstractGer |
• Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. |
| abstract_unstemmed |
• Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
6 |
| title_short |
Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide |
| url |
https://doi.org/10.1016/j.tiv.2013.04.015 |
| remote_bool |
true |
| author2 |
Chess-Williams, R. Mills, K.A. Kang, S.H. Farr, S.E. Grant, G.D. Perkins, A.V. Davey, A.K. Anoopkumar-Dukie, S. |
| author2Str |
Chess-Williams, R. Mills, K.A. Kang, S.H. Farr, S.E. Grant, G.D. Perkins, A.V. Davey, A.K. Anoopkumar-Dukie, S. |
| ppnlink |
ELV009047719 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.tiv.2013.04.015 |
| up_date |
2024-07-06T20:58:36.266Z |
| _version_ |
1803864785569185793 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022017968</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623162810.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.tiv.2013.04.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013013000029.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022017968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0887-2333(13)00122-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.92</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McDermott, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Effects of pyocyanin and lipopolysaccharide on urothelial cells assessed. • Decreased Ach and increased PGE2 release following treatment with virulence factors. • Decreased cell viability and induction of IL-6 detected. • Inflammation and altered urothelial mediators may contribute to UTI symptoms of pain and urgency.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PGE2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pyocyanin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipopolysaccharide</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acetylcholine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelium</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chess-Williams, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mills, K.A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, S.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farr, S.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grant, G.D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perkins, A.V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davey, A.K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anoopkumar-Dukie, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Janssen, Matthew ELSEVIER</subfield><subfield code="t">Prenatal diagnostic testing decisions in twin pregnancies in the era of cell-free DNA screening</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the European Society of Toxicology in Vitro</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV009047719</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1693-1698</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.tiv.2013.04.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.92</subfield><subfield code="j">Gynäkologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2013</subfield><subfield code="e">6</subfield><subfield code="h">1693-1698</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.399617 |